IP Library Granted Patent US 9,567,595
Granted Patent B2
US 9,567,595 · App. 14/707,231 · Granted Feb 14, 2017

Type II restriction modification system methylation subunit of

Inventors: Brady D. Lee (West Richland, WA); Deborah T. Newby (Idaho Falls, ID); Jeffrey A. Lacey (Idaho Falls, ID); David N. Thompson (Idaho Falls, ID); Vicki S. Thompson (Idaho Falls, ID); William A. Apel (Jackson, WY); Francisco F. Roberto (Highlands Ranch, CO); David W. Reed (Idaho Falls, ID)
Assignee: Battelle Energy Alliance, LLC
C12N15/74C12N9/00C12N9/1007C12N9/52C12N15/87C12Y201/01072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,567,595
App. No.
14/707,231
Granted
Feb 14, 2017
Kind
B2
Abstract

Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering recombination inside or outside of a cell using isolated and/or purified polypeptides and/or nucleic acid sequences from Alicyclobacillus acidocaldarius.

Claims (30)

1. A vector comprising a first nucleic acid sequence encoding a polypeptide having at least 90% sequence identity to SEQ ID No: 2891 and a second nucleic acid sequence heterologous to the first nucleic acid sequence.

2. The vector of claim 1 , wherein the polypeptide has activity at or below about pH 8.

3. The vector of claim 1 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius.

4. The vector of claim 1 , wherein the polypeptide has activity as a DNA adenine methylase.

5. A vector comprising a first nucleic acid sequence encoding the polypeptide of SEQ ID NO: 2891 and a second nucleic acid sequence heterologous to the first nucleic acid sequence.

6. The vector of claim 5 , wherein the first nucleic acid sequence comprises SEQ ID NO: 2892.

7. A method of modulating or altering nucleic acid methylation in a cell, the method comprising:

providing the vector of claim 1 to a cell; and

expressing the first nucleic acid sequence to produce the polypeptide.

8. The method according to claim 7 , wherein the modulation or alteration of nucleic acid methylation occurs at or below about pH 8.

9. The method according to claim 7 , wherein the modulation or alteration of nucleic acid methylation occurs at a temperature at or above about 50 degrees Celsius.

10. The method according to claim 7 , wherein the polypeptide is glycosylated, pegylated, or otherwise post-translationally modified.

11. The method according to claim 7 , wherein the polypeptide has activity as a DNA adenine methylase.

12. The method according to claim 7 , wherein the polypeptide has activity at or below about pH 8.

13. The method according to claim 7 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius.

14. A method of modulating or altering nucleic acid methylation, the method comprising:

providing an isolated or purified polypeptide having at least 90% sequence identity to SEQ ID No: 2891 to a nucleotide sequence in which adenine demethylation is desired.

15. The method according to claim 14 , wherein the modulation or alteration of nucleic acid methylation occurs at or below about pH 8.

16. The method according to claim 14 , wherein the modulation or alteration of nucleic acid methylation occurs at a temperature at or above about 50 degrees Celsius.

17. The method according to claim 14 , wherein the purified or isolated polypeptide is glycosylated, pegylated, or otherwise post-translationally modified.

18. The method according to claim 14 , wherein the purified or isolated polypeptide has activity as a DNA adenine methylase.

19. The method according to claim 14 , wherein the purified or isolated polypeptide has activity at or below about pH 8.

20. The method according to claim 14 , wherein the purified or isolated polypeptide has activity at a temperature at or above about 50 degrees Celsius.

21. The vector of claim 5 , wherein the polypeptide has activity at or below about pH 8.

22. The vector of claim 5 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius.

23. The vector of claim 5 , wherein the polypeptide has activity as a DNA adenine methylase.

24. A vector comprising a first nucleic acid sequence encoding a polypeptide having at least 99% sequence identity to SEQ ID No: 2891 and a second nucleic acid sequence heterologous to the first nucleic acid sequence.

25. The vector of claim 24 , wherein the polypeptide has activity at or below about pH 8.

26. The vector of claim 24 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius.

27. The vector of claim 24 , wherein the polypeptide has activity as a DNA adenine methylase.

Assignments (1)
CONFIRMATORY LICENSE Recorded Aug 11, 2015
From: BATTELLE ENERGY ALLIANCE LLC.
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 036343/0424 →
Continuity (4)
Division 14055966 · Oct 17, 2013
Division 13604979 · Sep 6, 2012
Division 12800045 · May 5, 2010
Related Publication 20150259693A1 · Sep 17, 2015